← Evidence map

TrialVirology journal2011

Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment.

Zhao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21816062